118O Definitive results for NSCLC and bladder cancer cohorts in the phase IIa trial of visugromab (CTL-002) in advanced/metastatic anti-PD/PD-L1 relapsed/refractory solid tumors (G... by Melero, I., De Miguel, M.J., Casal, G. Alonso, De Velasco Oria, G.A., Ramelyte, E., Joerger, M., Martin-Liberal, J., König, D., Sayehli, C.M., Gromke, T., RodrÍguez-Ruiz, M.E., Calvo, E., Garralda, E., Soto-Castillo, J.J., Dummer, R., Villarrubia, J. Esteban, Goebeler, M-E., Fettes, P., Klar, K., Leo, E.

Get full text